A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

Clinical trial NCT06859424 · RECRUITING

Trial details

NCT number: NCT06859424
Sponsor: Center for International Blood and Marrow Transplant Research
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

AML (Acute Myelogenous Leukemia)Acute Lymphoid Leukemia (ALL)Acute Leukemia (Category)MDS (Myelodysplastic Syndrome)CML (Chronic Myelogenous Leukemia)CLL (Chronic Lymphocytic Leukemia)Prolymphocyctic Leukemia Chronic Myelomonocytic Leukemia (CMML)Myeloproliferative Neoplasm (MPN)Lymphoma Myelofibrosis

Start date: 2025-07-25
Primary completion: 2028-06-01
Enrollment: 358

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.